Patient & Survivor Care
From the Journals
SUDs rates highest in head, neck, and gastric cancer survivors
Alcohol use disorder was the most common type of SUD across multiple subtypes of cancer patients.
Conference Coverage
BC axillary dissection may be unnecessary for isolated tumor cells after NAC
A large study has addressed a key question in breast cancer surgery: what to do when isolated tumor cells are found in sentinel lymph nodes after...
From the Journals
Clinical Exams Fall Short in Second Breast Cancer Detection
A new study highlights the importance of mammogram screening and patient education regarding self-detection, say the authors.
From the Journals
Side Effects of Local Treatment for Advanced Prostate Cancer May Linger for Years
A new study compared long-term side effects in men with advanced prostate cancer who received initial local treatment with those who opted for...
From the Journals
Gastric Cancer Survival Differs by Race and Ethnicity
Researchers analyzed gastric cancer survival outcomes by race and ethnicity, treatment type, and a range of other factors.
Latest News
New Prior Auth Policy Tied to Delays, Discontinuation of Oral Cancer Meds
Patients subjected to a new prior authorization policy on an established drug had a sevenfold higher likelihood of stopping the drug within 120...
Latest News
‘Left in the Dark’: Prior Authorization Erodes Trust, Costs More
The major issue overall is the disconnect between the time spent waiting for prior authorization approvals and the necessity of many treatments....
Conference Coverage
Nodal Radiation May Make BC Axillary Dissection Unnecessary
A major trial finds that there’s no need to do both in breast cancer patients with just one or two positive sentinel lymph nodes.
Conference Coverage
Lower olanzapine dose just as effective for chemotherapy-induced nausea, vomiting
A 2.5-mg dose of olanzapine may be just as effective at preventing nausea and vomiting as the standard 10 mg with far less daytime drowsiness.
From the Journals
Serum Hormone Concentrations May Predict Aromatase Inhibitor Benefit for BC Prevention
Measuring estradiol, testosterone, and SHBG more widely to identify those postmenopausal women at high risk for breast cancer who would benefit...
Conference Coverage
Survival-Toxicity Trade-off With T-DM1 in HER+ Breast Cancer
Older patients with advanced HER2+ breast cancer do not experience a survival benefit with trastuzumab emtansine vs standard-of-care combination...